title: Hemolytic hyperbilirubinemia after percutaneous device closure of left ventricular pseudoaneurysm: a disregarded complication.
abstract: Surgical repair of a left ventricular pseudoaneurysm is challenging. Percutaneous closure with an AMPLATZER Septal Occluder (AGA Medical Corporation, Golden Valley, MN) has evolved to be an effective alternative to conventional surgery with less complication. We report a case of severe hemolytic hyperbilirubinemia and acute renal failure after percutaneous left ventricular pseudoaneurysm endoprothesis repair, which required conventional surgical repair through a left thoracotomy to treat this complication. The rationale and results of such an off-the-label usage of AMPLATZER Septal Occluder were reexamined. Residual leakages were not rare findings in the reviewed literature. The indications for this approach should be individualized.
authors: Division of Cardiovascular Surgery, Department of Surgery, National Cheng Kung University Hospital and College of Medicine, Tainan, Taiwan.
authors: Meng-Ta
authors: MT
authors: Tsai
authors: Cheng-Che
authors: CC
authors: Tseng
authors: Chung-Dann
authors: CD
authors: Kan
mesh_terms: D000368:Aged; D017541:Aneurysm, False / Q000601:surgery*; D006322:Heart Aneurysm / Q000601:surgery*; D006801:Humans; D006932:Hyperbilirubinemia / Q000209:etiology*; D008297:Male; D055989:Septal Occluder Device / Q000009:adverse effects*